BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giri S, Pathak R, Aryal MR, Karmacharya P, Bhatt VR, Martin MG. Incidence trend of esophageal squamous cell carcinoma: an analysis of Surveillance Epidemiology, and End Results (SEER) database. Cancer Causes Control. 2015;26:159-161. [PMID: 25376829 DOI: 10.1007/s10552-014-0485-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Andrici J, Eslick GD. Epidemiology and Risk Factors for Esophageal Cancer. In: Saba NF, El-rayes BF, editors. Esophageal Cancer. Cham: Springer International Publishing; 2015. pp. 1-23. [DOI: 10.1007/978-3-319-20068-2_1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
2 Kuwai T, Yamaguchi T, Imagawa H, Miura R, Sumida Y, Takasago T, Miyasako Y, Nishimura T, Iio S, Yamaguchi A, Kouno H, Kohno H, Ishaq S. Endoscopic submucosal dissection for early esophageal neoplasms using the stag beetle knife. World J Gastroenterol 2018; 24(15): 1632-1640 [PMID: 29686470 DOI: 10.3748/wjg.v24.i15.1632] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
3 Ma XL, Yao H, Wang X, Wei Y, Cao LY, Zhang Q, Zhang L. ILK predicts the efficacy of chemoradiotherapy and the prognosis of patients with esophageal squamous cell carcinoma. Oncol Lett 2019;18:4114-25. [PMID: 31579417 DOI: 10.3892/ol.2019.10768] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Xie SH, Mattsson F, Lagergren J. Incidence trends in oesophageal cancer by histological type: An updated analysis in Sweden. Cancer Epidemiol. 2017;47:114-117. [PMID: 28258029 DOI: 10.1016/j.canep.2017.02.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
5 Londono R, Badylak SF. Regenerative Medicine Strategies for Esophageal Repair. Tissue Eng Part B Rev 2015;21:393-410. [PMID: 25813694 DOI: 10.1089/ten.TEB.2015.0014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
6 Brusselaers N, Maret-Ouda J, Konings P, El-Serag HB, Lagergren J. Menopausal hormone therapy and the risk of esophageal and gastric cancer. Int J Cancer 2017;140:1693-9. [PMID: 28006838 DOI: 10.1002/ijc.30588] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
7 Sadrizadeh A, Bagheri R, Soltani E, Anvari K, Toussi MS, Moadikhah S. The Comparison of the Advantages of Neoadjuvant Chemoradiotherapy versus Postoperative Chemoradiotherapy: Outcomes in Esophageal Cancer Patients. J Gastrointest Cancer 2018;49:50-6. [PMID: 28025816 DOI: 10.1007/s12029-016-9899-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
8 Luo QY, Zhou SN, Pan WT, Sun J, Yang LQ, Zhang L, Qiu MZ, Yang DJ. A multi-kinase inhibitor APG-2449 enhances the antitumor effect of ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition. Biochem Pharmacol 2021;183:114318. [PMID: 33159967 DOI: 10.1016/j.bcp.2020.114318] [Reference Citation Analysis]
9 Wang CC, Chen X, Yin J, Qu J. An integrated framework for the identification of potential miRNA-disease association based on novel negative samples extraction strategy. RNA Biol 2019;16:257-69. [PMID: 30646823 DOI: 10.1080/15476286.2019.1568820] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
10 Arnold M, Laversanne M, Brown LM, Devesa SS, Bray F. Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030. Am J Gastroenterol. 2017;112:1247-1255. [PMID: 28585555 DOI: 10.1038/ajg.2017.155] [Cited by in Crossref: 141] [Cited by in F6Publishing: 118] [Article Influence: 28.2] [Reference Citation Analysis]
11 Li ZY, Li HF, Zhang YY, Zhang XL, Wang B, Liu JT. Value of long non-coding RNA Rpph1 in esophageal cancer and its effect on cancer cell sensitivity to radiotherapy. World J Gastroenterol 2020; 26(15): 1775-1791 [PMID: 32351293 DOI: 10.3748/wjg.v26.i15.1775] [Reference Citation Analysis]
12 Wang QL, Xie SH, Wahlin K, Lagergren J. Global time trends in the incidence of esophageal squamous cell carcinoma. Clin Epidemiol 2018;10:717-28. [PMID: 29950901 DOI: 10.2147/CLEP.S166078] [Cited by in Crossref: 37] [Cited by in F6Publishing: 18] [Article Influence: 9.3] [Reference Citation Analysis]
13 Mao N, Nie S, Hong B, Li C, Shen X, Xiong T. Association between alcohol dehydrogenase-2 gene polymorphism and esophageal cancer risk: a meta-analysis. World J Surg Oncol 2016;14:191. [PMID: 27450204 DOI: 10.1186/s12957-016-0937-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
14 He X, Li S, Shi W, Lin Q, Ma J, Liu Y, Feng T, Cao X. Cyclin A1 is associated with poor prognosis in oesophageal squamous cell carcinoma. Oncol Lett 2019;18:706-12. [PMID: 31289545 DOI: 10.3892/ol.2019.10377] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Gao F, Xu YL, Liu YJ, Sun MH. Outcomes of self-expandable metal stent placement for malignant oesophageal strictures. Clin Radiol 2020;75:156.e21-7. [PMID: 31703807 DOI: 10.1016/j.crad.2019.10.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]